SBIR/STTR Research Award
IN VIVO COMPATIBLE AND READILY INJECTABLE GOLD NANO CONSTRUCTS FOR TUMOR THERAPY
Award amount
$104,907Program and phase
SBIR · Phase IAward year
2008Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NANOPARTICLE BIOCHEM, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
The objective of this proposal is to develop nanoparticulate therapeutic products from the readily injectable Gold-198 (Au-198) nanoconstructs invented at the University of Missouri and licensed to Nanoparticle Biochem, Inc. The Phase I effort embodies three aims: (1) Optimization of synthetic protocols, large scale production, and quality control capabilities of Au-198 nanoparticles (NP) and their utility toward conjugations with Gum Arabic (GA) to produce 198-AuNP-GA for use as an injectable brachy agent in prostate tumor (and various other human cancers) therapy
Technology keywords
Not reported